Kiniksa Pharma Ltd (Class A) Live Stock Price Today, Share Analysis and Chart

Name: Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A
Rating: 2.675375
Author: Trendlyne DVM scores

Turnaround Potential

about

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The com...

56.53 1.26 (2.28%)

New 52W High today

340.5K

XNAS Volume

XNAS 04 May, 2026 2:12 PM (EDT)

Medium Financial Strength

50.0 / 100

Mid Valuation

42.5 / 100

Technically Bullish

71.5 / 100

Turnaround Potential These stocks have average financials and valuation, but strong momentum indicating buying interest View Similar Embed DVM

1Yr Price target upside is 12%

8 analysts

Kiniksa Pharma Ltd (Class A) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Kiniksa Pharma Ltd (Class A) Live Stock Price Today, Share Analysis and Chart

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The com...

New 52W High today

SWOT Analysis

Kiniksa Pharma Ltd (Class A) Live Price Chart